शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MEDICAMEQBSEMEDICAMEN BIOTECH LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 14 Aug, 2026 · 16:08 IST

Q1 FY27 results approved; Re 1 final dividend; books closed Sept 19-25

Profit growth above 25%Results View source PDFExplain this filing

MEDICAMEQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-8.4%Reaction day
₹238.00
prior close
₹232.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-8.5% vs market
Pharmaceuticals peers, median of 167sector-0.3%-8.1% vs sector

On the reaction day the stock moved 8.5 pts less than Nifty Microcap 250 and 8.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-0.8
15m
-0.6
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-8.4+0.1-8.5-0.3-8.1
Next day
-5.0+0.5-5.5-0.0-5.0
2d
-4.6-0.1-4.5-0.7-3.9
3d
+2.5+0.4+2.1-0.5+3.0
4d
+1.4+0.7+0.7-0.8+2.1
5d
-1.7+0.9-2.6-0.5-1.1
1w
+0.4+1.1-0.7-0.8+1.2
15d
+17.4+1.6+15.8+1.2+16.2
1m
+45.6-0.7+46.3+0.4+45.2
2m
+14.9-3.2+18.1-4.2+19.0
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medicamen Biotech posted Q1 FY27 standalone revenue of Rs 4,471 lakh (up about 15% YoY) and PAT of Rs 253 lakh (up about 54% YoY). Consolidated PAT was Rs 185 lakh. Board approved a Re 1 per share final dividend (10%) subject to AGM nod. Register of members closed Sept 19-25 for the 33rd AGM on Sept 26 via video conferencing. Auditor issued unmodified review report. Minor fines of about Rs 1.1 lakh each from BSE and NSE for past board composition lapses were already paid in June 2026.

Likely market impact

Strong profit growth and dividend cheer; minor past governance fine already settled, no fresh overhang.